ASTRO Release: Sildenafil Citrate Improves Overall Sexual Function of Prostate Cancer Patients Receiving Radiation Therapy

Published: Oct 29, 2012

BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Sildenafil citrate (SC), a phosphodiesterase type 5 inhibitor, administered before, during and after radiation therapy improved overall sexual function of prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting.

Back to news